(STL.News) – GE Healthcare Life Sciences will inaugurate an open-access lab at Alderley Park’s Mereside Campus, the UK’s largest single-site life sciences campus on the 30th of October. In partnership with Alderley Park, the facility will help small and medium sized enterprises (SMEs) accelerate their science through access to advanced technologies, services and training from GE Healthcare Life Sciences.
The partnership builds upon the collaborative research environment and coworking laboratories at Alderley Park. The expertise and technology from GE Healthcare Life Sciences will support SMEs from early stage R&D to process development through manufacturing. The lab will feature advanced protein and cell analysis technologies including ÄKTA systems for protein purification, Biacore 8K for drug discovery, and IN Cell Analyzer 6500HS for cellular imaging. The partnership will also provide valuable insights about the challenges SMEs face and opportunities to collaborate on solutions that will benefit the UK’s life sciences community.
The biotechnology industry in the UK is growing rapidly, making partnerships a key component of the industry’s success. According to the UK Office of Life Sciences, as of 2018, there were 5,870 life science companies in the UK employing 248,400 people and the top 25 global bioscience companies all had operations in the UK.
Kath Mackay, Managing Director, Alderley Park, says: “We’re thrilled to be launching this facility which will help accelerate our customers’ research and discovery aims. The new GE laboratory is an excellent addition to the highly specialised scientific services offered at the Park and complements the existing oncology, analytical and open access services.
Conor McKechnie, Chief Marketing Officer, GE Healthcare Life Sciences, says: “The start-up community at Alderley Park has the creativity, vision and scientific expertise to help transform medicine. Providing them access to our technologies and services is a natural part of our mission to accelerate and advance biotherapeutics.”
The partnership is already earning commendations from the industry. Steve Bates OBE, Chief Executive of the BioIndustry Association (BIA), says: “GE Healthcare Life Sciences is an important partner for the BIA and our community. This new lab will give our members early access and training for all the tools they need for drug discovery, protein science and bioprocessing research.”
GE Healthcare Life Sciences has been supporting UK biotech start-ups through its partnerships with Stevenage BioScience Catalyst (SBC) and Clustermarket, a leading online sharing marketplace. The opening of the lab at Alderley Park further demonstrates GEHC Life Sciences’ commitment to supporting the UK’s growth and success in biotech.
About GE Healthcare Life Sciences
GE Healthcare Life Sciences helps therapy innovators, researchers and healthcare providers accelerate how precision diagnostics and therapies are invented, made and used. Our products enable biological analysis, research, development and the manufacture of advanced therapies and vaccines. Life Sciences is part of the $19.8 billion healthcare business of GE (NYSE: GE). With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps efficiently improve outcomes for patients, healthcare providers, researchers, and life sciences companies around the world. Visit our website https://www.gehealthcare.com/about/life-sciences for more information.